Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Joanne M. Donovan

Cmo at Edgewise Therapeutics, Inc. (EWTX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $4.6M

Reported trades

Filed Stock Type Shares Price Value Since
Aug 14SEC EWTXEdgewise Therapeutics, Inc. Sell Plan 2,83915,227 held (−16%) $43.78 $124K -10.8%
Aug 14SEC EWTXEdgewise Therapeutics, Inc. Sell Plan 2,77912,448 held (−18%) $43.71 $121K -10.6%
Aug 14SEC EWTXEdgewise Therapeutics, Inc. Sell Plan 10412,344 held (−1%) $44.43 $5K -12.1%
Aug 14SEC EWTXEdgewise Therapeutics, Inc. Sell Plan 80011,544 held (−6%) $44.52 $36K -12.3%
Aug 14SEC EWTXEdgewise Therapeutics, Inc. Sell Plan 2,9198,625 held (−25%) $43.41 $127K -10.0%
May 5SEC EWTXEdgewise Therapeutics, Inc. Sell Plan 5,2304,367 held (−54%) $31.29 $164K +24.8%
May 5SEC EWTXEdgewise Therapeutics, Inc. Sell Plan 50,0004,367 held (−92%) $38.57 $1.9M +1.3%
Apr 2SEC EWTXEdgewise Therapeutics, Inc. Sell Plan 28,6629,597 held (−75%) $32.31 $926K +20.9%
Mar 31SEC EWTXEdgewise Therapeutics, Inc. Sell Plan 21,3389,597 held (−69%) $32.12 $685K +21.6%
Mar 30SEC EWTXEdgewise Therapeutics, Inc. Sell Plan 9,62316,332 held (−37%) $30.98 $298K +26.1%
Mar 30SEC EWTXEdgewise Therapeutics, Inc. Sell Plan 6,7359,597 held (−41%) $30.98 $209K +26.1%
  • Sell

    Cmo Joanne M. Donovan sold $124K of EWTX at $43.78 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Cmo Joanne M. Donovan sold $121K of EWTX at $43.71 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Cmo Joanne M. Donovan sold $5K of EWTX at $44.43 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Cmo Joanne M. Donovan sold $36K of EWTX at $44.52 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Cmo Joanne M. Donovan sold $127K of EWTX at $43.41 — cuts the stake by 25%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Cmo Joanne M. Donovan sold $164K of EWTX at $31.29 — cuts the stake by 54%; pre-scheduled 10b5-1 plan sale.